Antagonism of VEGF-A–induced increase in vascular permeability by an integrin α3β1-Shp-1-cAMP/PKA pathway

Soo Hyeon Kim(Chungnam National University), Dong Wan Seo(Dankook University), Byung Joon Hwang(Seoul National University), William G. Stetler‐Stevenson(Center for Cancer Research), Hyeonju Kim(Dankook University), Joa Sub Oh(Dankook University), Hyejin Ko(Seoul National University), Yong Kee Kim(Sookmyung Women's University), Seo-Jin Lee(Shingyeong University), Yongwan Cho(Sookmyung Women's University), Eun-Kyung Ahn(Gyeonggi Research Institute), Young‐Rak Cho(Gyeonggi College of Science and Technology)
Blood
October 18, 2012
10.1182/blood-2012-05-428243
Cited by 51

Related Papers

TIMP-2 Mediated Inhibition of Angiogenesis
|Cell|2003|510
Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements)
|Gut|2020|332
Autoimmune Chronic Pancreatitis
|The American Journal of Gastroenterology|2004|288
TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase
|Brain Research|1992|282
Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin.
|PubMed|2000|279